Recovery of 157 COVID-19 patients with tailored treatment regime: a single centre study at dedicated COVID hospital in India

Authors

  • Prafulla Samant Department of Intensive care unit, Bhaktivedanta Hospital and Research Institute, Thane, Mumbai, Maharashtra, India http://orcid.org/0000-0001-5776-3357
  • Ajay Godse Department of Pulmonology, Bhaktivedanta Hospital and Research Institute, Thane, Mumbai, Maharashtra, India
  • Swapnil Gautam Department of Medicine, Bhaktivedanta Hospital and Research Institute, Thane, Mumbai, Maharashtra, India
  • Ajay Sankhe Department of Pediatrics, Bhaktivedanta Hospital and Research Institute, Thane, Mumbai, Maharashtra, India
  • Sivaprasad Gourabathini Department of Urology, Bhaktivedanta Hospital and Research Institute, Thane, Mumbai, Maharashtra, India
  • Rishikesh Karpe Department of Preventive and Social Medicine, Bhaktivedanta Hospital and Research Institute, Thane, Mumbai, Maharashtra, India
  • VijayKumar Gawali Department of Medical Research, Bhaktivedanta Hospital and Research Institute, Thane, Mumbai, Maharashtra, India
  • Heena Ali Department of Medical Research, Bhaktivedanta Hospital and Research Institute, Thane, Mumbai, Maharashtra, India
  • Mayur Bagul Department of Medical Research, Bhaktivedanta Hospital and Research Institute, Thane, Mumbai, Maharashtra, India

DOI:

https://doi.org/10.18203/2394-6040.ijcmph20205404

Keywords:

COVID-19, SARS-cov-2, Coronavirus, Pandemic

Abstract

Background: The regimen in treatment of COVID-19 disease patients is quite variable, with wide range of outcomes. We present our successful recovery rates of COVID-19 disease patients with our tailored treatment based on comorbidity and clinical symptoms.

Methods: We retrospectively analysed 157 consecutive discharged patients with COVID‐19 from 20th March 2020 to 20th May 2020. They were admitted and treated at Pandit Bhimsen Joshi general hospital.

Results: The Gender distribution was 86 (54.8 %) males and 71 (45.2%) females. Mean length of hospital stay was 13 days. Among the total of 157 patients, 41(26.1%) had co-morbidities. Study results revealed that patients with comorbidities have three times (OR=2.92) higher risk of death compared with patients without any comorbidities. Diabetic patients have four times (OR=4.1) higher risk of death compared with patients without any comorbidities. X-ray of patients showed 88% had no pulmonary involvement, 6.3% bilateral alveolar shadow, 3.18% unilateral alveolar shadow and 2.54% unilateral consolidation.

Conclusions: Generally, focus is on fever as primary symptom, our majority patients were asymptomatic. Three tailor made regimens approach for asymptomatic, mild cases and moderate to severe COVID-19 cases yielded in good recovery rate. Study results revealed that patients with comorbidities have three times (OR=2.92) higher risk of death compared with patients without any comorbidities. Diabetic patients have four times (OR=4.1) higher risk of death compared with patients without any comorbidities.

Author Biographies

Prafulla Samant, Department of Intensive care unit, Bhaktivedanta Hospital and Research Institute, Thane, Mumbai, Maharashtra, India

Department - ICU Designation - Senior ICU Consultant

Ajay Godse, Department of Pulmonology, Bhaktivedanta Hospital and Research Institute, Thane, Mumbai, Maharashtra, India

Consultant pulmonary and sleep medicine

Pulmonology

Bhaktivedanta hospital and Research Institute

Bhaktivedanta Swami Marg

Shrishti complex, sector 1

Mira road E Thane 401017

 

Swapnil Gautam, Department of Medicine, Bhaktivedanta Hospital and Research Institute, Thane, Mumbai, Maharashtra, India

Consultant Internal Medicine

Department - Medicine 

Bhaktivedanta hospital and Research Institute

Bhaktivedanta Swami Marg

Shrishti complex, sector 1

Mira road E Thane 401017

Ajay Sankhe, Department of Pediatrics, Bhaktivedanta Hospital and Research Institute, Thane, Mumbai, Maharashtra, India

Director Bhaktivedanta Hospital

Pediatric Department

Bhaktivedanta hospital and Research Institute

Bhaktivedanta Swami Marg

Shrishti complex, sector 1

Mira road E Thane 401017

Sivaprasad Gourabathini, Department of Urology, Bhaktivedanta Hospital and Research Institute, Thane, Mumbai, Maharashtra, India

Consultant Urology

Urology department

Bhaktivedanta hospital and Research Institute

Bhaktivedanta Swami Marg

Shrishti complex, sector 1

Mira road E Thane 401017

Rishikesh Karpe, Department of Preventive and Social Medicine, Bhaktivedanta Hospital and Research Institute, Thane, Mumbai, Maharashtra, India

Consultant preventive and social medicine

Preventive and Social medicine department

Bhaktivedanta hospital and Research Institute

Bhaktivedanta Swami Marg

Shrishti complex, sector 1

Mira road E Thane 401017

VijayKumar Gawali, Department of Medical Research, Bhaktivedanta Hospital and Research Institute, Thane, Mumbai, Maharashtra, India

Head of Clinical Research department

Medical research department

Bhaktivedanta hospital and Research Institute

Bhaktivedanta Swami Marg

Shrishti complex, sector 1

Mira road E Thane 401017

Heena Ali, Department of Medical Research, Bhaktivedanta Hospital and Research Institute, Thane, Mumbai, Maharashtra, India

Senior Clinical Research Coordinator

Medical Research Department

Bhaktivedanta hospital and Research Institute

Bhaktivedanta Swami Marg

Shrishti complex, sector 1

Mira road E Thane 401017

Mayur Bagul, Department of Medical Research, Bhaktivedanta Hospital and Research Institute, Thane, Mumbai, Maharashtra, India

Clinical Research Coordinator

Medical Research Department

Bhaktivedanta hospital and Research Institute

Bhaktivedanta Swami Marg

Shrishti complex, sector 1

Mira road E Thane 401017

References

Bret AN. Coronavirus Disease 2019 (COVID-19): A Global Crisis. Medscape. 2020. Available from: https://reference.medscape.com/slideshow/2019-novel-coronavirus-6012559. Accessed on 14 June 2020.

Lu R, Zhao X, Li J, Niu P, Yang B, Wu H et al. Articles Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020;395(10224):565-74.

Letko M, Marzi A, Munster V. Functional assessment of cell entry and receptor usage for SARS-CoV-2 and another lineage B beta coronavirus. Nat Microbiol. 2003;5(4):562-9.

Kulkarni A, Bhosale S. Is A Problem Shared, A Problem Halved? Not Always! The Novel Coronavirus COVID-19 Outbreak. Indian J Critical Care Med. 2020;24(2):88-9.

Press Release. Indian Council of Medical Research. Government of India. Main.icmr.nic.in. 2020. Available from: https://main.icmr.nic.in/press-release. Accessed on 14 June 2020.

Guo Y, Cao Q, Hong Z, Tan Y, Chen S, Jin H et al. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak-an update on the status. Military Med Res. 2020;7(1).

Cascella M, Rajnik M, Cuomo A, Dulebohn SC, Di Napoli R. Features, Evaluation and Treatment Coronavirus (COVID-19). StatPearls. 2020.

Yan Y, Shin W, Pang Y, Meng Y, Lai J, You C et al. The First 75 Days of Novel Coronavirus (SARS-CoV-2) Outbreak: Recent Advances, Prevention, and Treatment. Int J Envir Res Pub Heal. 2020;17(7):2323.

Velavan T, Meyer C. The COVID‐19 epidemic. Trop Med Int Health. 2020;25(3):278-80.

Gao J, Tian Z, Yang X. Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. Bio sci Trends. 2020;14(1):72-3.

Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 2020;30(3):269-71.

Wang W, Tang J, Wei F. Updated understanding of the outbreak of 2019 novel coronavirus (2019‐nCoV) in Wuhan, China. Journal of Medical Virology. 2020;92(4):441-447.

Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respiratory Med. 2020;8(5):475-81.

Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China. JAMA. 2020;323(11):1061.

Li H, Wang YM, Xu JY, Cao B, Jie Z et al. Potential antiviral therapeutics for 2019 Novel Coronavirus; Chinese J tuberculosis and Respiratory Dis. 2020;43(0):E002.

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet. 2020;395(10223):497-506.

Read S, Obeid S, Ahlenstiel C, Ahlenstiel G. The Role of Zinc in Antiviral Immunity. Adv Nutr. 2019;10(4):696-710.

Chu C. Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings. Thorax. 2004;59(3):252-6.

Lim J, Jeon S, Shin H, Kim M, Seong Y, Lee W et al. Case of the Index Patient Who Caused Tertiary Transmission of Coronavirus Disease 2019 in Korea: The Application of Lopinavir/Ritonavir for the Treatment of COVID-19 Pneumonia Monitored by Quantitative RT-PCR. J Kor Med Sci. 2020;35(6).

Cao B, Wang Y, Wen D, Liu W, Wang J, Fan G et al. A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19. New Eng J Med. 2020;382(19):1787-1799.

Sharifi A, Vahedi H, Nedjat S, Rafiei H, Hosseinzadeh‐Attar M. Effect of single‐dose injection of vitamin D on immune cytokines in ulcerative colitis patients: a randomized placebo‐controlled trial. APMIS. 2019;127(10):681-7.

Gombart A, Pierre A, Maggini S. A Review of Micronutrients and the Immune System–Working in Harmony to Reduce the Risk of Infection. Nutri. 2020;12(1):236.

Cannell J, Vieth R, Umhau J, Holick M, Grant W, Madronich S et al. Epidemic influenza and vitamin D. Epidemiol Infect. 2006;134(6):1129-40.

Alipio MM, Alipio MM. Vitamin D supplementation could possibly improve clinical outcomes of patients infected with Coronavirus-2019 (COVID- 2019) Vitamin D supplementation could possibly improve clinical outcomes of patients infected with Coronavirus-2019. COVID-19. 2020;2019(082):1-9.

Jaillon S, Berthenet K, Garlanda C. Sexual Dimorphism in Innate Immunity. Clin Reviews Alle Immunol. 2017;56(3):308-21.

Chu J, Yang N, Wei Y, Yue H, Zhang F, Zhao J et al. Clinical characteristics of 54 medical staff with COVID‐19: A retrospective study in a single center in Wuhan, China. J Med Virol. 2020;92(7):807-13.

Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507-13.

Booth C. Clinical Features and Short-term Outcomes of 144 Patients with SARS in the Greater Toronto Area. JAMA. 2003;289(21):2801.

Downloads

Published

2020-12-25

How to Cite

Samant, P., Godse, A., Gautam, S., Sankhe, A., Gourabathini, S., Karpe, R., Gawali, V., Ali, H., & Bagul, M. (2020). Recovery of 157 COVID-19 patients with tailored treatment regime: a single centre study at dedicated COVID hospital in India. International Journal Of Community Medicine And Public Health, 8(1), 119–124. https://doi.org/10.18203/2394-6040.ijcmph20205404

Issue

Section

Original Research Articles